Home visits by nurse may help reduce mortality in moms, children

July 07, 2014

Women who had prenatal and infant/toddler nurse visits at home were less likely to die than women who did not and children whose mothers were visited by nurses were less likely to have died by age 20 from preventable causes.

Since 1990, the authors have been conducting a randomized clinical trial of a program of prenatal and infant/toddler home visits by nurses for very low-income, largely black mothers, having their first child.

The study assigned 1,138 mothers to 1 of 4 treatment groups: treatment 1 (transportation for prenatal care, n=166), treatment 2 (transportation plus developmental screening for infants and toddlers, n=514), treatment 3 (transportation plus prenatal/postnatal home visits, n=230), and treatment 4 (transportation, screening, and prenatal, postpartum, and infant/toddler home visits through age 2 years, n=228). The authors analyzed all cause-mortality in mothers and preventable-cause mortality, including sudden infant death syndrome, unintentional injury and homicide, in children. The study period stretched from 1990 to 2011. The goal of the nurses is to improve maternal and child health by helping to support women's motivations to protect their children and themselves.

The average 21-year maternal all-cause mortality rate was 3.7 percent in the combined control group (treatments 1 and 2), 0.4 percent in treatment 3, and 2.2 percent in treatment 4. When the children were 20 years of age, the preventable-cause child mortality rate was 1.6 percent in treatment 2 and 0 percent in treatment 4.

"These findings should be replicated in well-powered trials with populations at very high levels of familial and neighborhood risk."
-end-
Author: David L. Olds, Ph.D., of the University of Colorado, Aurora, and colleagues.

(JAMA Pediatr. Published online July 7, 2014. doi:10.1001/jamapediatrics.2014.472. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: Authors made conflict of interest disclosures. The current phase of this research was supported with funding from the National Institute of Drug Abuse. Please see article for additional information, including other authors, author contributions and affiliations, etc.

Media Advisory: To contact author David L. Olds, Ph.D., call Mark Couch at 303-724-5377 or email mark.couch@ucdenver.edu

The JAMA Network Journals

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.